Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.

In this population-based propensity score matched (PSM) cohort study, we aimed to investigate the risk of developing dementia with the use of acid suppressants, including proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2 antagonists). Cohorts of PPI users (n = 2,778), H2 antagon...

Full description

Bibliographic Details
Main Authors: Chia-Liang Wu, Wei-Yi Lei, Jaw-Shing Wang, Ching-En Lin, Chien-Lin Chen, Shu-Hui Wen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0242975
_version_ 1818904548220076032
author Chia-Liang Wu
Wei-Yi Lei
Jaw-Shing Wang
Ching-En Lin
Chien-Lin Chen
Shu-Hui Wen
author_facet Chia-Liang Wu
Wei-Yi Lei
Jaw-Shing Wang
Ching-En Lin
Chien-Lin Chen
Shu-Hui Wen
author_sort Chia-Liang Wu
collection DOAJ
description In this population-based propensity score matched (PSM) cohort study, we aimed to investigate the risk of developing dementia with the use of acid suppressants, including proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2 antagonists). Cohorts of PPI users (n = 2,778), H2 antagonist users (n = 6,165), and non-users (n = 86,238) were selected from a dataset covering the years 2000 to 2010 in Taiwan's National Health Insurance Research Database. Patients in the three groups were PSM at a ratio of 1:1 within each comparison cohort (CC). Three CCs were created: (1) PPI users compared to non-users (CC1, n = 2,583 pairs); (2) H2 antagonist users compared to non-users (CC2, n = 5,955 pairs); and (3) PPI users compared to H2 antagonist users (CC3, n = 2,765 pairs). A multivariable robust Cox proportional hazard model was used to estimate the adjusted hazard ratio (aHR) and the 95% confidence interval (CI) for the risk of developing dementia. The multivariable analysis results show that the aHR of developing dementia during the follow-up period was 0.72 (CC1: 95% CI = 0.51-1.03, P = 0.07) for PPI users and 0.95 (CC2: 95% CI = 0.74-1.22, P = 0.69) for H2 antagonist users, when compared to non-users. Between the patients using acid suppressants, there was no difference between PPI and H2 antagonist users in the risk of developing dementia (CC3: aHR = 0.82, 95% CI = 0.58-1.17, P = 0.28). In conclusion, no association was observed between the use of acid suppressants and the risk of developing dementia in any of the three CCs. Further, randomized controlled trials are warranted to confirm this relationship.
first_indexed 2024-12-19T21:09:11Z
format Article
id doaj.art-eab691a50b2d464dae317920f2370dc8
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T21:09:11Z
publishDate 2020-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-eab691a50b2d464dae317920f2370dc82022-12-21T20:05:33ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011511e024297510.1371/journal.pone.0242975Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.Chia-Liang WuWei-Yi LeiJaw-Shing WangChing-En LinChien-Lin ChenShu-Hui WenIn this population-based propensity score matched (PSM) cohort study, we aimed to investigate the risk of developing dementia with the use of acid suppressants, including proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2 antagonists). Cohorts of PPI users (n = 2,778), H2 antagonist users (n = 6,165), and non-users (n = 86,238) were selected from a dataset covering the years 2000 to 2010 in Taiwan's National Health Insurance Research Database. Patients in the three groups were PSM at a ratio of 1:1 within each comparison cohort (CC). Three CCs were created: (1) PPI users compared to non-users (CC1, n = 2,583 pairs); (2) H2 antagonist users compared to non-users (CC2, n = 5,955 pairs); and (3) PPI users compared to H2 antagonist users (CC3, n = 2,765 pairs). A multivariable robust Cox proportional hazard model was used to estimate the adjusted hazard ratio (aHR) and the 95% confidence interval (CI) for the risk of developing dementia. The multivariable analysis results show that the aHR of developing dementia during the follow-up period was 0.72 (CC1: 95% CI = 0.51-1.03, P = 0.07) for PPI users and 0.95 (CC2: 95% CI = 0.74-1.22, P = 0.69) for H2 antagonist users, when compared to non-users. Between the patients using acid suppressants, there was no difference between PPI and H2 antagonist users in the risk of developing dementia (CC3: aHR = 0.82, 95% CI = 0.58-1.17, P = 0.28). In conclusion, no association was observed between the use of acid suppressants and the risk of developing dementia in any of the three CCs. Further, randomized controlled trials are warranted to confirm this relationship.https://doi.org/10.1371/journal.pone.0242975
spellingShingle Chia-Liang Wu
Wei-Yi Lei
Jaw-Shing Wang
Ching-En Lin
Chien-Lin Chen
Shu-Hui Wen
Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
PLoS ONE
title Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
title_full Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
title_fullStr Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
title_full_unstemmed Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
title_short Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
title_sort acid suppressants use and the risk of dementia a population based propensity score matched cohort study
url https://doi.org/10.1371/journal.pone.0242975
work_keys_str_mv AT chialiangwu acidsuppressantsuseandtheriskofdementiaapopulationbasedpropensityscorematchedcohortstudy
AT weiyilei acidsuppressantsuseandtheriskofdementiaapopulationbasedpropensityscorematchedcohortstudy
AT jawshingwang acidsuppressantsuseandtheriskofdementiaapopulationbasedpropensityscorematchedcohortstudy
AT chingenlin acidsuppressantsuseandtheriskofdementiaapopulationbasedpropensityscorematchedcohortstudy
AT chienlinchen acidsuppressantsuseandtheriskofdementiaapopulationbasedpropensityscorematchedcohortstudy
AT shuhuiwen acidsuppressantsuseandtheriskofdementiaapopulationbasedpropensityscorematchedcohortstudy